NRSG 5800: EXAM 1 | Questions with 100% Verified Answers | Latest Update

NRSG 5800: EXAM 1 | Questions with 100% Verified Answers | Latest Update

Question: what must all prescriptions contain
Answer:
- superscription
- inscription
- signutura
- subscription
- prescriber identification (name, NPI)

Question: what is the superscription in a prescription
Answer:
date, name, identiying information and rx symbol

Question: inscription of a prescription
Answer:
medication, amount, strength (250 mg of amoxicillan)

Question: subscription part of a prescription (disp)
Answer:
directions to the pharmacy on how much and how many, and refills (ie: 35 tablets . 2 refils)

Question: Signatura (sig) on prescription
Answer:
directions to the patient (ie take 1 tablet PO by mouth daily for 7 days), need to include if PRN
why to take it

Question: how many ml are in a tsp
Answer:
5 ml

Question: what weight conversion do you use for pediactric patients
Answer:
kg. 1 lb = 2.2

,Question: PR abbreviation
Answer:
per rectum

Question: TP abbreviation
Answer:
topical

Question: SL abbreviation
Answer:
sublingual

Question: QWK abbreviation
Answer:
every week

Question: IN abbreviation
Answer:
intranasal

Question: when writing a prescription for a controlled substance what
else do you need to include
Answer:
- 3rd pt identifier
- DEA number, handwritten signature

Question: pre-phase in drug approvment process
Answer:
animal testing, wherre FDA decides if safe to do for human testing

Question: clinical testing of IND: phase 1
Answer:
in healthy normal patients to monitor safety and dosage and see SE

,Question: phase 2 in clincal testing of IND
Answer:
trials of those with the disease to see if theres any effect on the disease or any SE, others will
recieve a placebo (main purpose efficacy and SE)

Question: phase 3 of IND clincal testing
Answer:
compares new treatment with old treatmments to see which is better, different populations and
dosages or those using other drugs (main purpose efficacy and monitoring for adverse
reactions)

Question: when do clinical trials begin
Answer:
after IND application placed and reviewed by FDA and IRB (local institutional review board)

Question: who approves clinical trial protocols and who may
participate
Answer:
IRB

Question: phase 4 of IND
Answer:
test on many thousands with disease and is often where rare SE are seen (main purpose: safety
and efficacy)

Question: what is a NDA
Answer:
formal step for new drug application to ask FDA to approve drug, occurs after clinical trials
completed

Question: accelerated approval in drug testing
Answer:
can be given to new drugs for serious and life threatning illnesses that lack treatment and are
evaluated by surragate endpoints

, Question: what are surrogate endpoints
Answer:
ways to evaluate effectiviness in accelerated drug approval like labs etc that may show
possible benefit

Question: what drug was approved for accelerated drug approval that
helps thousands of babies
Answer:
survanta

Question: emergency use authorization of drugs
Answer:
known potential benefits outweigh the known and potential risk

Question: example of emergency use authorizatiion drug
Answer:
covid 19 vaccine

Question: what is the orphan drug progrom
Answer:
provides financial incentive to sponsers that tx rare diseases

Question: what is off label use of a drug
Answer:
approved drug by the FDA but not approved for that reason or approved at different doses

Question: what is compassionate use in drug prescriptions
Answer:
those with life threatning conditions can gain access to investigational drugs when no other tx
available

Question: what is a teratogenic effect
Answer:
cause negative SE on fetus, now required to be clearly labled (for lactation and child bearing
age)